Related Experiment Videos

Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb

J Hatzfeld1, M L Li, E L Brown

  • 1Laboratoire C.N.R.S. de Biologie Cellulaire et Moléculaire des Facteurs de Croissance, ICIG, Hôpital Paul-Brousse, Villejuif, France.

Insights

Antisense oligonucleotides targeting transforming growth factor beta (TGF-beta) and retinoblastoma susceptibility (Rb) released early hematopoietic cells from quiescence. Autocrine TGF-beta negatively regulates early hematopoietic progenitor cycling via Rb.

Area of Science:

  • Hematology
  • Cell Biology
  • Molecular Biology

Background:

  • Hematopoietic stem cell proliferation is tightly regulated.
  • Transforming growth factor beta (TGF-beta) and antioncogenes like retinoblastoma susceptibility (Rb) and p53 are implicated in cell cycle control.

Purpose of the Study:

  • To investigate the roles of TGF-beta, Rb, and p53 in the negative regulation of early hematopoietic cell proliferation.
  • To elucidate the mechanism by which autocrine TGF-beta affects progenitor cell cycling.

Main Methods:

  • Use of antisense oligonucleotides to inhibit gene expression of TGF-beta, Rb, and p53.
  • Colony formation assays for multi-lineage progenitors.
  • Single cell culture and limiting dilution analysis to detect autocrine factors.

Main Results:

  • Antisense TGF-beta and antisense Rb enhanced progenitor colony formation, while antisense p53 did not.
  • Autocrine TGF-beta is produced by a subpopulation of early progenitors.
  • Rb antisense partially reversed TGF-beta inhibition, suggesting a common pathway.

Conclusions:

  • Autocrine TGF-beta negatively regulates early hematopoietic progenitor cycling.
  • This regulation involves interaction with the Rb gene product.
  • TGF-beta and Rb act through a common pathway to control hematopoietic progenitor proliferation.

Related Concept Videos